[HTML][HTML] Pathologic response and residual tumor cellularity after neo-adjuvant chemotherapy predict prognosis in breast cancer patients

D Gentile, A Sagona, C De Carlo, B Fernandes… - The Breast, 2023 - Elsevier
Introduction Residual tumor cellularity (RTC) and pathologic complete response (pCR) after
neo-adjuvant chemotherapy (NAC) are prognostic factors associated with improved …

Assessing risks and knowledge gaps on the impact of systemic therapies in early breast cancer on female fertility: A systematic review of the literature

G Gentile, S Scagnoli, L Arecco, D Santini… - Cancer Treatment …, 2024 - Elsevier
The therapeutic landscape for early breast cancer (eBC) has expanded by introducing novel
anticancer agents into clinical practice. During their reproductive years, women with eBC …

[HTML][HTML] Bibliometric analysis and visualization of endocrine therapy for breast cancer research in the last two decade

D Wang, Y Yang, L Yang, H Yang - Frontiers in Endocrinology, 2023 - frontiersin.org
Background Breast cancer endocrine therapy research has become a crucial domain in
oncology since hormone receptor-positive breast cancers have been increasingly …

[HTML][HTML] A fusion deep learning framework based on breast cancer grade prediction

W Tao, Z Zhang, X Liu, M Yang - Digital Communications and Networks, 2023 - Elsevier
In breast cancer grading, the subtle differences between HE-stained pathological images
and the insufficient number of data samples lead to grading inefficiency. With its rapid …

Radiothérapie des cancers du sein: questions d'actualité en 2023

MA Bollet, S Racadot, S Rivera, A Arnaud… - Cancer …, 2023 - Elsevier
Résumé La radiothérapie a une place majeure dans la prise en charge des patients atteints
de cancer du sein car en situation postopératoire elle améliore les taux de contrôle local et …